Spot Acne Treatment Oil Free 0.75oz

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. This can be done one to three times daily, depending on the patient's needs and the physician's guidance.

It is advisable to initiate treatment with one application per day to minimize the risk of excessive skin drying. Based on the patient's response, the frequency may be gradually increased to two or three times daily as necessary or as directed by a healthcare provider. Should the patient experience dryness or peeling, it is recommended to reduce the application frequency to once daily or every other day.

For patients who will be exposed to sunlight, the application of sunscreen is recommended following the use of this product. In cases where irritation or sensitivity occurs, the use of both the product and sunscreen should be discontinued, and the patient should consult a healthcare professional for further advice.

Contraindications

Use of this product is contraindicated in individuals with very sensitive skin. Due to the potential for increased skin irritation and dryness, concurrent use with other topical acne medications is not recommended. If irritation becomes severe, discontinue use and consult a healthcare professional.

Warnings and Precautions

Skin irritation and dryness may be exacerbated by the concurrent use of other topical acne medications. It is advised that only one topical acne treatment be utilized at a time to minimize the risk of irritation.

Healthcare professionals should counsel patients to avoid unnecessary sun exposure and to apply sunscreen regularly. Direct contact with the eyes, lips, and mouth should be strictly avoided, as well as contact with hair and dyed fabrics, as this product may cause bleaching.

Patients may experience skin irritation, which can manifest as redness, burning, itching, peeling, or swelling. To alleviate these symptoms, it may be beneficial to reduce the frequency of application or to use a lower concentration of the product. This treatment is not recommended for individuals with very sensitive skin.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be instructed to discontinue use and consult a healthcare provider if irritation worsens.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if they concurrently use another topical acne medication. Such irritation may manifest as redness, burning, itching, peeling, or swelling. To mitigate these effects, it is recommended that patients limit the frequency of application or consider using a lower concentration of the product.

In clinical practice, it is advised that patients avoid unnecessary sun exposure and utilize sunscreen to protect the skin. Additionally, contact with the eyes, lips, and mouth should be strictly avoided, as well as contact with hair and dyed fabrics, which may be bleached by the product.

Patients with very sensitive skin should refrain from using this product. If irritation worsens, it is imperative to discontinue use and consult a healthcare professional.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended. It is crucial to keep this product out of reach of children to prevent accidental ingestion.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To minimize this risk, it is advised to use only one topical acne medication at a time.

In the event that irritation or sensitivity develops, it is recommended to discontinue the use of both products and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Spot Acne Treatment Oil Free 0.75oz (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Depending on the patient's response and under the guidance of a healthcare professional, the frequency may be gradually increased to two or three times daily. Should any dryness or peeling of the skin occur, the application frequency should be reduced to once a day or every other day.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. The use of salicylic acid is generally contraindicated in pregnancy due to potential risks to the fetus, including the possibility of teratogenic effects. Pregnant women are advised to consult a healthcare provider before using this product to discuss potential risks and alternative options.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous evaluation of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that they should not use the product if they have very sensitive skin, as this may exacerbate their condition.

Patients should be instructed to discontinue use and consult a doctor if they experience severe irritation. Additionally, healthcare providers should emphasize that the likelihood of skin irritation and dryness increases if the patient is using another topical acne medication concurrently. Therefore, patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F). Care should be taken to ensure that the product is kept within this temperature range to maintain its integrity and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. To minimize the risk of excessive skin drying, patients should begin with one application daily and may gradually increase to two or three times daily as needed or as directed by a healthcare professional.

Clinicians should counsel patients to apply sunscreen if they plan to be outdoors after using the product. In the event of irritation or sensitivity, patients are advised to discontinue use of both the product and any sunscreen, and to consult a doctor.

Drug Information (PDF)

This file contains official product information for Spot Acne Treatment Oil Free 0.75oz, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)